JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Cash Flow Statement
Cash Flow Statement
JW (Cayman) Therapeutics Co Ltd
Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | ||
---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||
Net Income |
(1 664)
|
0
|
(702)
|
0
|
(846)
|
0
|
|
Depreciation & Amortization |
24
|
0
|
48
|
0
|
87
|
0
|
|
Other Non-Cash Items |
1 359
|
0
|
35
|
0
|
231
|
0
|
|
Cash Interest Paid |
5
|
6
|
6
|
6
|
7
|
10
|
|
Change in Working Capital |
20
|
(250)
|
58
|
(651)
|
(9)
|
(404)
|
|
Cash from Operating Activities |
(261)
N/A
|
(435)
-67%
|
(561)
-29%
|
(651)
-16%
|
(537)
+18%
|
(404)
+25%
|
|
Investing Cash Flow | |||||||
Capital Expenditures |
(130)
|
(142)
|
(137)
|
(74)
|
(101)
|
(79)
|
|
Other Items |
38
|
0
|
0
|
(54)
|
(24)
|
54
|
|
Cash from Investing Activities |
(92)
N/A
|
(142)
-55%
|
(137)
+4%
|
(127)
+7%
|
(124)
+2%
|
(25)
+80%
|
|
Financing Cash Flow | |||||||
Net Issuance of Common Stock |
2 849
|
2 142
|
1
|
(1)
|
0
|
0
|
|
Net Issuance of Debt |
37
|
(12)
|
(13)
|
(18)
|
119
|
224
|
|
Other |
(27)
|
(43)
|
(18)
|
(2)
|
(7)
|
(10)
|
|
Cash from Financing Activities |
2 859
N/A
|
2 087
-27%
|
(31)
N/A
|
(21)
+32%
|
112
N/A
|
214
+90%
|
|
Change in Cash | |||||||
Effect of Foreign Exchange Rates |
(131)
|
(163)
|
(67)
|
112
|
97
|
(32)
|
|
Net Change in Cash |
2 376
N/A
|
1 346
-43%
|
(796)
N/A
|
(687)
+14%
|
(451)
+34%
|
(247)
+45%
|
|
Free Cash Flow | |||||||
Free Cash Flow |
(391)
N/A
|
(577)
-48%
|
(698)
-21%
|
(724)
-4%
|
(637)
+12%
|
(483)
+24%
|